9 – 10 May 2026
Business Design Centre, London

Preserving Brainspan: Understanding Neurologic Blood Biomarkers within Preventive Cognitive Care

Dr. Sita Kedia, MD, Chief Medical Office, Neurologist and Functional Medicine Specialist, PALM HEALTH, Ladue, MO, United States

Dr. Sita Kedia, MD, MPH, FAHS, IFMCP, is a physician specializing in preventive and integrative medicine, affiliated with PALM Health in St. Louis, Missouri. With expertise in clinical diagnostics and cognitive health, her work focuses on translating emerging scientific evidence into practical strategies that support long-term brain health and personalized preventive care.

The session of Dr. Kedia at the Longevity Med Summit equips longevity medicine physicians with a clear, evidence-based framework for the ethical and effective incorporation of neurologic blood biomarkers into preventive cognitive care.

The session “Preserving Brainspan: Understanding Neurologic Blood Biomarkers within Preventive Cognitive Care,” explores how plasma-based neurologic biomarkers—such as phosphorylated tau (p-tau217), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) are transforming early detection of neurodegenerative processes, often years before cognitive symptoms appear. The session provides longevity medicine physicians with an evidence-based framework for ethically integrating these biomarkers into clinical practice, balancing benefits, risks, and patient-centered considerations. Drawing on recent research and clinical data, Dr. Kedia outlines practical approaches for patient selection, testing, counseling, and targeted interventions, including lifestyle strategies and emerging therapeutics to help clinicians personalize care and extend brain health.